Alteration of drug biotransformation and elimination during infection and inflammation

Pharmacology & Therapeutics
Kenneth W Renton

Abstract

During infection or inflammation, the expression of cytochrome P450 and its dependent biotransformation pathways are modified. This results in a change in the capacity of the liver to handle drugs and in alterations in the production and elimination of endogenous substances throughout the body. The majority of the CYP isoforms are modified at pre-translational steps in protein synthesis, and, in most cases, cytokines are involved as mediators of the response. Recent information suggests that inflammatory responses that are localized to the CNS cause a loss of CYP within the brain. This is accompanied by a parallel down-regulation of CYP in peripheral organs that is mediated by a signaling pathway between the brain and periphery. This review covers the loss that occurs in the major mammalian CYP families in response to infection/inflammation and the mediator pathways that are key to this response.

References

Oct 21, 1978·Lancet·J A FleethamP W Munt
Nov 22, 1976·Biochemical and Biophysical Research Communications·K W Renton, G J Mannering
Apr 1, 1976·Clinical Pharmacology and Therapeutics·G M TrenholmeP E Carson
Apr 1, 1975·Clinical Pharmacology and Therapeutics·R J ElinS M Wolff
Jul 7, 1992·Biochemical Pharmacology·Y L ChenL Chauvelot-Moachon
Jun 1, 1990·Canadian Journal of Physiology and Pharmacology·K W Renton, L C Knickle
Jul 1, 1991·Canadian Journal of Physiology and Pharmacology·S M Moochhala, K W Renton
Jan 1, 1991·International Journal of Immunopharmacology·S Moochhala, K W Renton
Jan 1, 1991·International Journal of Immunopharmacology·S Azri, K W Renton
Jan 1, 1990·European Journal of Clinical Pharmacology·H OkunoY Sameshima
May 1, 1986·Biochemical Pharmacology·T C Peterson, K W Renton
Jan 1, 1986·Annual Review of Pharmacology and Toxicology·G J Mannering, L B Deloria
Oct 24, 1987·Lancet·S J WilliamsG C Farrell
Jun 1, 1989·British Journal of Clinical Pharmacology·J H JonkmanT W Guentert
Aug 1, 1988·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·K J GouldenK W Renton
Jun 15, 1987·Life Sciences·S I ShedlofskyC J McClain
Dec 1, 1986·Infection and Immunity·P GhezziC A Dinarello
Nov 1, 1986·British Journal of Clinical Pharmacology·S J Williams, G C Farrell
Jun 1, 1985·Clinical Pharmacology and Therapeutics·J SonneP B Andreasen
Jan 1, 1985·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·G Koren, M Greenwald
Mar 1, 1973·Journal of the National Cancer Institute·T H Corbett, P Nettesheim
Apr 1, 1970·Biochemical Pharmacology·J S McCarthyR E Stitzel
Nov 1, 1983·The Journal of Pharmacy and Pharmacology·P GaltierM Franc
Jun 30, 1982·Biochemical and Biophysical Research Communications·G SinghN Stebbing
Mar 1, 1984·Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes·E A El-BassiouniA Abdel-Rafee
Feb 29, 1984·Biochemical and Biophysical Research Communications·P GhezziM Salmona

❮ Previous
Next ❯

Citations

Mar 7, 2012·Archives of Toxicology·Márcia CarvalhoMaria de Lourdes Bastos
Dec 14, 2004·Journal of Neurology·Helen Tremlett, Joel Oger
Dec 18, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jun ZhangEdward T Morgan
Jul 30, 2009·The Journal of Pharmacology and Experimental Therapeutics·Wei ZouPatricia E Ganey
Jan 13, 2006·Annual Review of Pharmacology and Toxicology·Alison E AitkenEdward T Morgan
Sep 14, 2007·BMC Microbiology·Wendy RodenburgIngeborg M J Bovee-Oudenhoven
Nov 4, 2004·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Radim VrzalZdenek Dvorák
Jul 12, 2013·Case Reports in Transplantation·Arin S JantzA Osama Gaber
Mar 15, 2003·Drug Metabolism Reviews·Shufeng ZhouJames W Paxton
Dec 8, 2015·Experimental and Therapeutic Medicine·Zein Shaban Ibrahim
Mar 12, 2011·Toxicology Letters·Alexander Batista-DuharteErnesto Oviedo-Orta
Mar 4, 2008·Aquatic Toxicology·Stéphane ReynaudPatrick Ravanel
Nov 13, 2007·The American Journal of Geriatric Pharmacotherapy·Andrew L MasicaE Wesley Ely
Jun 28, 2005·Pharmacotherapy·Gregory EschenauerRandolph E Regal
Jun 24, 2009·Journal of Clinical Pharmacology·Carolina de Miranda SilvaVera Lucia Lanchote
Sep 19, 2007·British Journal of Clinical Pharmacology·Staffan OhlssonQun-Ying Yue
Jan 24, 2009·Journal of Veterinary Pharmacology and Therapeutics·J N KingP Lees
Mar 5, 2010·Fundamental & Clinical Pharmacology·Marc Le VeeOlivier Fardel
Jul 26, 2012·Alcoholism, Clinical and Experimental Research·Dirk TheileSebastian Mueller
May 7, 2010·Journal of Veterinary Pharmacology and Therapeutics·H BártíkováB Szotáková
May 3, 2005·Acta Tropica·Dayse A Manhães-RochaFrancisco J R Paumgartten
Nov 22, 2005·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Siu-Lung Chan, John H K Yeung
Jan 22, 2013·Drug Metabolism Reviews·Sabine Gerbal-ChaloinMartine Daujat-Chavanieu
Mar 18, 2006·British Journal of Clinical Pharmacology·Sarah M RobertsonScott R Penzak
May 16, 2012·Critical Reviews in Toxicology·Edward L LeCluyseMark J Powers
Sep 30, 2009·Expert Opinion on Drug Metabolism & Toxicology·Olivier Fardel, Marc Le Vée

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.